Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
These findings indicate that miR-152 inhibited breast cancer growth and metastasis through negative regulation of ROCK1 expression.
|
30982494 |
2020 |
Breast Carcinoma
|
0.380 |
Biomarker
|
disease |
BEFREE |
These findings indicate that miR-152 inhibited breast cancer growth and metastasis through negative regulation of ROCK1 expression.
|
30982494 |
2020 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
Our results confirm the action of melatonin on the miR-152-3p regulation known to be involved in the progression of breast cancer.
|
29990486 |
2018 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
As expected, miR-148a-3p, miR-148b-3p or miR-152-3p could increase Adriamycin sensitivity in breast cancer cells in vitro.
|
29743122 |
2018 |
Breast Carcinoma
|
0.380 |
Biomarker
|
disease |
BEFREE |
As expected, miR-148a-3p, miR-148b-3p or miR-152-3p could increase Adriamycin sensitivity in breast cancer cells in vitro.
|
29743122 |
2018 |
Breast Carcinoma
|
0.380 |
Biomarker
|
disease |
BEFREE |
Our results confirm the action of melatonin on the miR-152-3p regulation known to be involved in the progression of breast cancer.
|
29990486 |
2018 |
Malignant neoplasm of breast
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
By using human clinical specimens, we also showed that miR-152 expression levels were negatively correlated with β-catenin and PKM2 levels in breast cancer tissues.
|
29162853 |
2017 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
BEFREE |
Human breast cancer cell line HCC1806 was transfected with hsa-miR-152-3p mimic, inhibitor, or scrambled negative controls.
|
28247844 |
2017 |
Malignant neoplasm of breast
|
0.380 |
Biomarker
|
disease |
CTD_human |
In conclusion, H19 promoted proliferation and invasion of breast cancer through the miR-152/DNMT1 axis, providing a novel mechanism about the occurrence and development of breast cancer.
|
28544374 |
2017 |
Malignant neoplasm of breast
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
WITHDRAWN: Downregulation of MicroRNA-152 and Inhibition of Cell Proliferation, Migration, and Invasion in Breast Cancer.
|
28653610 |
2017 |
Breast Carcinoma
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
WITHDRAWN: Downregulation of MicroRNA-152 and Inhibition of Cell Proliferation, Migration, and Invasion in Breast Cancer.
|
28653610 |
2017 |
Breast Carcinoma
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
By using human clinical specimens, we also showed that miR-152 expression levels were negatively correlated with β-catenin and PKM2 levels in breast cancer tissues.
|
29162853 |
2017 |
Breast Carcinoma
|
0.380 |
Biomarker
|
disease |
BEFREE |
Human breast cancer cell line HCC1806 was transfected with hsa-miR-152-3p mimic, inhibitor, or scrambled negative controls.
|
28247844 |
2017 |
Breast Carcinoma
|
0.380 |
Biomarker
|
disease |
CTD_human |
In conclusion, H19 promoted proliferation and invasion of breast cancer through the miR-152/DNMT1 axis, providing a novel mechanism about the occurrence and development of breast cancer.
|
28544374 |
2017 |
Malignant neoplasm of breast
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
|
27475839 |
2016 |
Breast Carcinoma
|
0.380 |
AlteredExpression
|
disease |
BEFREE |
DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
|
27475839 |
2016 |
Malignant neoplasm of breast
|
0.380 |
PosttranslationalModification
|
disease |
BEFREE |
DNMT1, the DNA methyltransferase 1 for the maintenance methylation, is aberrantly up-regulated in BC and its overexpression is responsible for hypermethylation of miR-148a and miR-152 promoters.
|
22935141 |
2013 |
Breast Carcinoma
|
0.380 |
PosttranslationalModification
|
disease |
BEFREE |
DNMT1, the DNA methyltransferase 1 for the maintenance methylation, is aberrantly up-regulated in BC and its overexpression is responsible for hypermethylation of miR-148a and miR-152 promoters.
|
22935141 |
2013 |
Hepatitis, Toxic
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Drug-Induced Liver Disease
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
|
28544374 |
2017 |
Hepatitis, Drug-Induced
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Mammary Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152.
|
28544374 |
2017 |
Drug-Induced Acute Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |
Chemical and Drug Induced Liver Injury
|
0.300 |
Biomarker
|
disease |
CTD_human |
"Serum microRNA signatures as ""liquid biopsies"" for interrogating hepatotoxic mechanisms and liver pathogenesis in human."
|
28545106 |
2017 |